MedTrace Logo

Management of Drug Hypersensitivity in Children

NCT02031120 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2025-03-19

No results posted yet for this study

Summary

The aim of this study is (1) to assess the incidence of suspected drug allergies in a pediatric hospital and the proportion in which these reactions are confirmed to be allergic; (2) to evaluate the diagnostic values of the different allergy tests available; (3) to investigate the pathophysiology of drug allergies, particularly by investigating the role of viruses, and by performing HLA typing and a gene expression profile both in the acute phase of the reaction and 2 months later.

Conditions

  • Drug Hypersensitivity

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Jean-Christoph Caubet, MD · University Hospital, Geneva

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-21
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031120 on ClinicalTrials.gov